{"id":"https://openalex.org/W2138104853","doi":null,"title":"THE EFFECT OF PIOGLITAZONE ON ADIPOSITY, ADIPONECTIN AND CAROTID ARTERY INTIMAL THICKNESS IN OBESE BUT OTHERWISE HEALTHY MINORITY SUBJECTS","display_name":"THE EFFECT OF PIOGLITAZONE ON ADIPOSITY, ADIPONECTIN AND CAROTID ARTERY INTIMAL THICKNESS IN OBESE BUT OTHERWISE HEALTHY MINORITY SUBJECTS","publication_year":2008,"publication_date":"2008-12-01","ids":{"openalex":"https://openalex.org/W2138104853","mag":"2138104853"},"language":"en","primary_location":{"id":"pmh:oai:CiteSeerX.psu:10.1.1.861.8343","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.861.8343","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.sid.ir/en/VEWSSID/J_pdf/101120080401.pdf","raw_type":"text"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086007895","display_name":"Behrouz Salehian","orcid":"https://orcid.org/0000-0002-1611-2811","observed_orcids":["https://orcid.org/0000-0002-1611-2811"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Behrouz Salehian","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1611-2811","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067372300","display_name":"Josephine Bilas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Josephine Bilas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002062668","display_name":"Vahid Pirhajati Mahabadi","orcid":"https://orcid.org/0000-0002-3219-7800","observed_orcids":["https://orcid.org/0000-0002-3219-7800","https://orcid.org/0000-0002-7461-6559"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vahid Pirhajati Mahabadi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7461-6559","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044668713","display_name":"V Aleli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V Aleli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Kris Norris","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kris Norris","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5103837678","display_name":"Shally Bhasin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shally Bhasin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"6","issue":"4","first_page":"162","last_page":"174"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12979","display_name":"Cardiovascular Disease and Adiposity","score":0.4074999988079071,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12979","display_name":"Cardiovascular Disease and Adiposity","score":0.4074999988079071,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.38600000739097595,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.09679999947547913,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":1.0},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.6930000185966492},{"id":"https://openalex.org/keywords/adiponectin","display_name":"adiponectin","score":0.9940000176429749},{"id":"https://openalex.org/keywords/carotid-intimal-thickness","display_name":"carotid intimal thickness","score":0.9330000281333923},{"id":"https://openalex.org/keywords/intramuscular-fat","display_name":"intramuscular fat","score":0.9950000047683716},{"id":"https://openalex.org/keywords/stroke-prevention","display_name":"stroke prevention","score":0.6909999847412109},{"id":"https://openalex.org/keywords/peripheral-vascular-disease","display_name":"peripheral vascular disease","score":0.9929999709129333},{"id":"https://openalex.org/keywords/minority-groups","display_name":"minority groups","score":0.6790000200271606},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.7549999952316284}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9348559379577637},{"id":"https://openalex.org/C2776782570","wikidata":"https://www.wikidata.org/wiki/Q357439","display_name":"Adiponectin","level":4,"score":0.8047301769256592},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7222768664360046},{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.7115994691848755},{"id":"https://openalex.org/C2780221984","wikidata":"https://www.wikidata.org/wiki/Q131191","display_name":"Body mass index","level":2,"score":0.6011994481086731},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.47053584456443787},{"id":"https://openalex.org/C61427482","wikidata":"https://www.wikidata.org/wiki/Q6656244","display_name":"Anthropometry","level":2,"score":0.43287211656570435},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.4289630353450775},{"id":"https://openalex.org/C2780005051","wikidata":"https://www.wikidata.org/wiki/Q797258","display_name":"Body fat percentage","level":3,"score":0.41341933608055115},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.3662912845611572},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.24343231320381165},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.18594083189964294},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.18569225072860718}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:CiteSeerX.psu:10.1.1.861.8343","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.861.8343","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.sid.ir/en/VEWSSID/J_pdf/101120080401.pdf","raw_type":"text"},{"id":"mag:2138104853","doi":null,"is_oa":false,"landing_page_url":"https://www.sid.ir/en/VEWSSID/J_pdf/101120080401.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4306514215","display_name":"Intern J Endocrinol Metab","issn_l":"1726-913X","issn":["1726-913X","1726-9148"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-70","russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Endocrinology and Metabolism","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W174705705","https://openalex.org/W1830151520","https://openalex.org/W1965393911","https://openalex.org/W1968375269","https://openalex.org/W1975561886","https://openalex.org/W1997030483","https://openalex.org/W1998524503","https://openalex.org/W2027323593","https://openalex.org/W2031125972","https://openalex.org/W2031466315","https://openalex.org/W2036240669","https://openalex.org/W2042033329","https://openalex.org/W2046889389","https://openalex.org/W2048717385","https://openalex.org/W2053454761","https://openalex.org/W2057420463","https://openalex.org/W2062560800","https://openalex.org/W2064617441","https://openalex.org/W2066771373","https://openalex.org/W2071519765","https://openalex.org/W2071871820","https://openalex.org/W2076641670","https://openalex.org/W2078535741","https://openalex.org/W2084561741","https://openalex.org/W2086591008","https://openalex.org/W2089235913","https://openalex.org/W2092509345","https://openalex.org/W2100560936","https://openalex.org/W2103156933","https://openalex.org/W2107529930","https://openalex.org/W2110804432","https://openalex.org/W2112220590","https://openalex.org/W2114528799","https://openalex.org/W2123387995","https://openalex.org/W2134195140","https://openalex.org/W2139409926","https://openalex.org/W2143808884","https://openalex.org/W2156538361","https://openalex.org/W3138780921"],"related_works":["https://openalex.org/W2386109160","https://openalex.org/W2155053499","https://openalex.org/W2467482145","https://openalex.org/W2003515701","https://openalex.org/W2355505183","https://openalex.org/W7098101913","https://openalex.org/W1975282928","https://openalex.org/W1491642176","https://openalex.org/W2136491667","https://openalex.org/W1987677069"],"abstract_inverted_index":{"tion,":[0],"blood":[1],"pressure,":[2],"Body":[3],"Mass":[4],"Index":[5],"(BMI)":[6],"and":[7,31,41,64,95,116],"anthropometric":[8],"measures":[9],"of":[10,28,34,91,103,109,114],"subjects":[11],"in":[12,38,55,61,66,76,111,120],"the":[13,77,89,92,107,112],"three":[14],"groups":[15,39,79],"were":[16],"not":[17,60],"statistically":[18],"different.":[19],"Af-":[20],"ter":[21],"6":[22],"months,":[23],"we":[24],"observed":[25,87],"significant":[26,32],"decrease":[27],"intramuscular":[29],"fat":[30,37],"increase":[33],"subcutaneous":[35],"thigh":[36,98],"B":[40],"C":[42,68],"as":[43],"compared":[44],"to":[45],"group":[46,56,62,67],"A.":[47],"The":[48],"average":[49],"carotid":[50],"artery":[51],"intimal":[52],"thickness":[53],"increased":[54],"A":[57,81],"(p<0.01),":[58],"but":[59],"B,":[63],"decreased":[65],"(p<0.01).":[69],"Serum":[70],"adiponectin":[71,93],"levels":[72,94],"rose":[73],"sharply":[74],"(p<0.001)":[75],"treatment":[78],"only.":[80],"signifi-":[82],"cant":[83],"positive":[84],"correlation":[85],"was":[86],"between":[88],"change":[90],"subcu-":[96],"taneous":[97],"fat.":[99],"Conclusion":[100],":":[101],"Results":[102],"this":[104],"study":[105],"supports":[106],"use":[108],"pioglitazone":[110],"prevention":[113],"stroke":[115],"peripheral":[117],"vascular":[118],"disease":[119],"high-risk":[121],"populations.":[122]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}